Based on the above information, our data verified that M2-CM VEGF-dependently increased the expression levels of GSC-associated genes, including CD133, OCT4, and Nanog, in the GBM cells (Figures 4(e)–4(h)). The gene discussed is POU5F1; the disease is glioblastoma.